| Year |
Citation |
Score |
| 2017 |
Barasch N, Gong X, Kwei KA, Varma S, Biscocho J, Qu K, Xiao N, Lipsick JS, Pelham RJ, West RB, Pollack JR. Recurrent rearrangements of the Myb/SANT-like DNA-binding domain containing 3 gene (MSANTD3) in salivary gland acinic cell carcinoma. Plos One. 12: e0171265. PMID 28212443 DOI: 10.1371/Journal.Pone.0171265 |
0.376 |
|
| 2017 |
Kuo H, Hsieh S, Sirisawad M, Chen C, Cheung LW, Schweighofer KJ, Hsu C, Fu C, Liu J, Wu S, Eckert K, Wang H, Apatira M, Dhami K, Kwei K, et al. Abstract 4197: Interaction of B lymphoma cells with the microenvironment affects ibrutinib sensitivity Cancer Research. 77: 4197-4197. DOI: 10.1158/1538-7445.Am2017-4197 |
0.314 |
|
| 2015 |
Clarke N, Biscocho J, Kwei KA, Davidson JM, Sridhar S, Gong X, Pollack JR. Integrative Genomics Implicates EGFR as a Downstream Mediator in NKX2-1 Amplified Non-Small Cell Lung Cancer. Plos One. 10: e0142061. PMID 26556242 DOI: 10.1371/Journal.Pone.0142061 |
0.431 |
|
| 2014 |
Sweeney RT, McClary AC, Myers BR, Biscocho J, Neahring L, Kwei KA, Qu K, Gong X, Ng T, Jones CD, Varma S, Odegaard JI, Sugiyama T, Koyota S, Rubin BP, et al. Identification of recurrent SMO and BRAF mutations in ameloblastomas. Nature Genetics. 46: 722-5. PMID 24859340 DOI: 10.1038/Ng.2986 |
0.341 |
|
| 2014 |
McClary AC, Sweeney RT, Biscocho J, Myers BR, Neahring L, Kwei KA, Qu K, Gong X, Ng T, Jones CD, Varma S, Odegaard JI, Rubin B, Troxell ML, Pelham RJ, et al. Abstract 3436: Ameloblastoma driver mutations revealed by next-generation sequencing of formalin-fixed paraffin-embedded specimens Cancer Research. 74: 3436-3436. DOI: 10.1158/1538-7445.Am2014-3436 |
0.352 |
|
| 2012 |
Kwei KA, Baker JB, Pelham RJ. Modulators of sensitivity and resistance to inhibition of PI3K identified in a pharmacogenomic screen of the NCI-60 human tumor cell line collection. Plos One. 7: e46518. PMID 23029544 DOI: 10.1371/Journal.Pone.0046518 |
0.465 |
|
| 2011 |
Kwei KA, Shain AH, Bair R, Montgomery K, Karikari CA, van de Rijn M, Hidalgo M, Maitra A, Bashyam MD, Pollack JR. SMURF1 amplification promotes invasiveness in pancreatic cancer. Plos One. 6: e23924. PMID 21887346 DOI: 10.1371/Journal.Pone.0023924 |
0.422 |
|
| 2009 |
Kim YH, Kwei KA, Girard L, Salari K, Kao J, Pacyna-Gengelbach M, Wang P, Hernandez-Boussard T, Gazdar AF, Petersen I, Minna JD, Pollack JR. Genomic and functional analysis identifies CRKL as an oncogene amplified in lung cancer. Oncogene. 29: 1421-30. PMID 19966867 DOI: 10.1038/Onc.2009.437 |
0.452 |
|
| 2009 |
Kao J, Salari K, Bocanegra M, Choi YL, Girard L, Gandhi J, Kwei KA, Hernandez-Boussard T, Wang P, Gazdar AF, Minna JD, Pollack JR. Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery. Plos One. 4: e6146. PMID 19582160 DOI: 10.1371/Journal.Pone.0006146 |
0.359 |
|
| 2008 |
Demetriou MC, Kwei KA, Powell MB, Nagle RB, Bowden GT, Cress AE. Integrin A6 Cleavage in Mouse Skin Tumors. The Open Cancer Journal. 2: 1-4. PMID 20664806 DOI: 10.2174/1874079000802010001 |
0.597 |
|
| 2008 |
Bergamaschi A, Kim YH, Kwei KA, La Choi Y, Bocanegra M, Langerød A, Han W, Noh DY, Huntsman DG, Jeffrey SS, Børresen-Dale AL, Pollack JR. CAMK1D amplification implicated in epithelial-mesenchymal transition in basal-like breast cancer. Molecular Oncology. 2: 327-39. PMID 19383354 DOI: 10.1016/J.Molonc.2008.09.004 |
0.433 |
|
| 2008 |
Kwei KA, Bashyam MD, Kao J, Ratheesh R, Reddy EC, Kim YH, Montgomery K, Giacomini CP, Choi YL, Chatterjee S, Karikari CA, Salari K, Wang P, Hernandez-Boussard T, Swarnalata G, et al. Genomic profiling identifies GATA6 as a candidate oncogene amplified in pancreatobiliary cancer. Plos Genetics. 4: e1000081. PMID 18535672 DOI: 10.1371/Journal.Pgen.1000081 |
0.442 |
|
| 2008 |
Kwei KA, Kim YH, Girard L, Kao J, Pacyna-Gengelbach M, Salari K, Lee J, Choi YL, Sato M, Wang P, Hernandez-Boussard T, Gazdar AF, Petersen I, Minna JD, Pollack JR. Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer. Oncogene. 27: 3635-40. PMID 18212743 DOI: 10.1038/Sj.Onc.1211012 |
0.396 |
|
| 2006 |
Finch JS, Tome ME, Kwei KA, Bowden GT. Catalase reverses tumorigenicity in a malignant cell line by an epidermal growth factor receptor pathway. Free Radical Biology & Medicine. 40: 863-75. PMID 16520238 DOI: 10.1016/J.Freeradbiomed.2005.10.036 |
0.622 |
|
| 2006 |
Kwei KA, Finch JS, Ranger-Moore J, Bowden GT. The role of Rac1 in maintaining malignant phenotype of mouse skin tumor cells. Cancer Letters. 231: 326-38. PMID 15893875 DOI: 10.1016/J.Canlet.2005.02.031 |
0.642 |
|
| 2004 |
Kwei KA, Finch JS, Thompson EJ, Bowden GT. Transcriptional repression of catalase in mouse skin tumor progression. Neoplasia (New York, N.Y.). 6: 440-8. PMID 15548352 DOI: 10.1593/Neo.04127 |
0.627 |
|
| 2003 |
Butts BD, Kwei KA, Bowden GT, Briehl MM. Elevated basal reactive oxygen species and phospho-Akt in murine keratinocytes resistant to ultraviolet B-induced apoptosis. Molecular Carcinogenesis. 37: 149-57. PMID 12884366 DOI: 10.1002/Mc.10131 |
0.579 |
|
| 2001 |
Gupta A, Butts B, Kwei KA, Dvorakova K, Stratton SP, Briehl MM, Bowden GT. Attenuation of catalase activity in the malignant phenotype plays a functional role in an in vitro model for tumor progression. Cancer Letters. 173: 115-25. PMID 11597785 DOI: 10.1016/S0304-3835(01)00656-5 |
0.598 |
|
| Show low-probability matches. |